The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Albright Charles since year 2005.
The trader's CIK number is 1682323.
At the time of the last reporting, Albright Charles was the Chief Scientific Officer of Editas Medicine, Inc. .
(stock ticker symbol EDIT).
See this page for all insider trading activities at Editas Medicine, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-07||EDIT||Editas Medicine, Inc.||Sale||622||26.95||16,762|
|2020-02-03||EDIT||Editas Medicine, Inc.||Sale||5,549||26.54||147,287|
|2020-01-31||EDIT||Editas Medicine, Inc.||Option Ex||17,977||.00||0|
|2018-06-13||EDIT||Editas Medicine, Inc.||Option Ex||10,000||16.51||165,100|
|2018-06-13||EDIT||Editas Medicine, Inc.||Sale||10,000||35.98||359,799|
|2018-05-23||EDIT||Editas Medicine, Inc.||Sale||10,000||35.00||350,000|
|2018-05-23||EDIT||Editas Medicine, Inc.||Option Ex||10,000||16.51||165,100|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Albright Charles (Chief Scientific Officer of Editas Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.